169 related articles for article (PubMed ID: 26171034)
1. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy.
Zhang ZS; Wang J; Shen YB; Guo CC; Sai KE; Chen FR; Mei X; Han FU; Chen ZP
Oncol Lett; 2015 Jul; 10(1):379-383. PubMed ID: 26171034
[TBL] [Abstract][Full Text] [Related]
2. Effect and molecular mechanism of mTOR inhibitor rapamycin on temozolomide-induced autophagic death of U251 glioma cells.
Li B; Zhou C; Yi L; Xu L; Xu M
Oncol Lett; 2018 Feb; 15(2):2477-2484. PubMed ID: 29434961
[TBL] [Abstract][Full Text] [Related]
3. [Toxic effects of Vitamin C combined with temozolomide on glioma cells and its mechanism].
Chen MS; Zhao HK; Cheng YY; Yuan ZH; Zhang YL
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):616-621. PubMed ID: 33719269
[No Abstract] [Full Text] [Related]
4. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin 1 and inhibiting autophagy.
Xu J; Huang H; Peng R; Ding X; Jiang B; Yuan X; Xi J
Exp Ther Med; 2018 Jun; 15(6):4798-4804. PubMed ID: 29805498
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
7. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
[TBL] [Abstract][Full Text] [Related]
8. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221
[TBL] [Abstract][Full Text] [Related]
9. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells.
Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA
Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668
[TBL] [Abstract][Full Text] [Related]
10. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells.
Huang XJ; Li CT; Zhang WP; Lu YB; Fang SH; Wei EQ
Pharmacology; 2008; 82(1):1-9. PubMed ID: 18408414
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin.
Ni Q; Fan Y; Zhang X; Fan H; Li Y
J Ethnopharmacol; 2019 Oct; 242():111699. PubMed ID: 31005632
[TBL] [Abstract][Full Text] [Related]
13. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of Beclin 1 enhances apoptosis by H2O2 in glioma U251 cells].
Kong XX; Zhang HY; Chen ZQ; Fan XF; Gong YS
Sheng Li Xue Bao; 2011 Jun; 63(3):238-44. PubMed ID: 21681342
[TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin and its anticancer activity against endometrial carcinoma and cervical cancer: involvement of apoptosis, autophagy and transferrin receptor.
Tang T; Xia Q; Xi M
Singapore Med J; 2021 Feb; 62(2):96-103. PubMed ID: 31680182
[TBL] [Abstract][Full Text] [Related]
18. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
19. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin suppresses glioma growth by repressing ERRα-mediated mitochondrial biogenesis.
Zhang W; Wang Y; Chen L; Chen H; Qi H; Zheng Y; Du Y; Zhang L; Wang T; Li Q
Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38072894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
